Melissa Hall

PHD Doctor of Philosophy,  Cleveland Clinic 

Location: Germany

Consulting Services

Grant Submission Research Consulting Legal Support Pharma-CRO-Device

Areas Of Interest

Mandrillus leucophaeus Chilaiditi Anomaly Arbitrating Extensor Rigidity Contrast Media Receptor, Gastrin-Releasing Peptide Stereoisomers Rhinitis GTPase-Deficient Dynamin Receptors, Somatomedin Agnosias, Sensory Johns Wort, Saint Pupillary Functions, Abnormal Transcription Factor, TCF4 Preexcitation Syndromes Brain Hemorrhage, Traumatic IMP Nucleotidase Drug-Induced Stevens Johnson Syndrome Neosar Complices, Solitary Nuclear Phosphatidylcholine NADP-Linked Benzaldehyde Dehydrogenase Glaucoma, Narrow Angle Para Athletes AE1 Gene Product Rhizaria Personal Identification System Transobturator Suburethral Tapes Adhesion Molecule, Junction Pyrophosphate Phosphohydrolase, Thiamine Gebauer Ethyl Chloride Comparative Anatomies Scapula Bibliography, Medical Ratany

Professional Narrative

Dr. Melissa Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Executive Director, Harvard Med 2001
Senior Director, Harvard Med 1987

Education

Bachelor of science in nursing, Perelman School of Medicine 2002
Doctor of medicine, Perelman School of Medicine 1992

Referees

Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02